Stockholders’ Equity - Schedule of Warrant Activity (Details) - Stock Warrants [Member] - USD ($) |
9 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Sep. 30, 2026 |
|
| Schedule of Warrant Activity [Line Items] | ||
| Number of Warrants,Beginning balance | 4,509,259 | |
| Weighted Average Exercise Price, Beginning balance | $ 3.14 | |
| Weighted Average Remaining Contractual Term (Years), balance | 2 years 6 months 25 days | 2 years 8 months 8 days |
| Aggregate Intrinsic Value, Beginning balance | ||
| Number of Warrants, Granted | 6,165,691 | |
| Weighted Average Exercise Price, Granted | $ 0.96 | |
| Number of Warrants, Exercised | (3,007,654) | |
| Weighted Average Exercise Price, Exercised | $ 1.2 | |
| Number of Warrants, Ending balance | 7,667,296 | |
| Weighted Average Exercise Price, Ending balance | $ 2.58 | |
| Aggregate Intrinsic Value, Ending balance | ||
| Number of Warrants, Exercisable | 7,667,296 | |
| Weighted Average Exercise Price, Exercisable | $ 2.58 | |
| Weighted Average Remaining Contractual Term (Years), Exercisable | 2 years 8 months 8 days | |
| Aggregate Intrinsic Value, Exercisable |
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are exercisable as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercised weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period granted. No definition available.
|
| X | ||||||||||
- Definition Amount by which the aggregate intrinsic value outstanding. No definition available.
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under other than options. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|